Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials

International Journal of Hyperthermia

Volumn 29, Issue 2, 2013, Pages 156-167

  Mi, Deng Hai ^a,b   Li, Zheng ^a,b   Yang, Ke Hu ^a   Cao, Nong ^a   Lethaby, Anne ^a,c   Tian, Jin Hui ^a   Santesso, Nancy ^a,d   Ma, Bin ^a   Chen, Yao Long ^a   Liu, Ya Li ^a  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Gastric cancer; Hyperthermia; Intraperitoneal chemotherapy; Meta analysis; Radical surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ANASTOMOSIS LEAKAGE; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; GASTROINTESTINAL DISEASE; HUMAN; HYPERTHERMIC THERAPY; ILEUS; INTESTINE PERFORATION; INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; META ANALYSIS; PATIENT SAFETY; STOMACH CANCER; SYSTEMATIC REVIEW;

EID: 84874039783     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.768359     Document Type: Article

References (59)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity. J Surg Oncol 2011;104:692-698.
3. Chen J, Su Y, Song Z, Lin LM. Clinical application of postoperative intraperitoneal hyperthermic perfusion combined with venoclysis for gastric cancer. Chin J Cancer Prev Treat 2006;13:937-938.
4. Chen SR, Zhao F, Tan ZW, Lv JS. Efficacy of intraoperative hyperthermic intraperitoneal chemotherapy for patients with advanced gastric carcinoma. J Youjiang Med Coll Nation 2005;27:357.
5. Chen ZX, Hu JK, Cheng Z, Chen JP, Peng DS, Tao QP. Positive results of therapy of gastric cancer patients after operation by intraperitoneal hyperthermic chemotherapy. J Chin Pract Med 2001;3:39-40 & 44.
6. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529-534.
7. Fujimura T, Yonemura Y, Muraoka K, Takamura H, Hirono Y, Sahara H, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study. World J Surg 1994;18:150-155.
8. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048-2052.
9. Jin YF. Efficacy of intraoperative hyperthermic intraperitoneal chemotherapy for patients with advanced gastric carcinoma. Zhejiang J Clin Med 2007;9:357-358.
10. Wang FL, Hou AJ, Peng Z. Clinical study of hypotonic intraoperative intraperitoneal chemohyperthermia for gastric cancer. Clin J Med Offic 2006;34:17-19.
11. Wang MY, Sun G, Zhou JP, He FL. Clinical application of intraperitoneal hyperthermia chemoperfusion in the operation for the advanced gastric cancer. World J Med Today 2002;3:293-294.
12. Wang SW. The analysis for curative effect of intraoperative hyperthermic intraperitoneal chemotherapy combined with postoperative veins chemotherapy. Chron Pathem J (China) 2010;12:404-405.
13. Ye L, Jiang T, Hu D, Xiong GY. Application of intraperitoneal peirtoneal hyperthermia chemoperfusion in advanced gastric cancer. Int Med Health Guid News (China) 2007;13:29-31.
14. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasionpositive gastric cancer. World J Surg 1995;19:450-454, discussion: 455.
15. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: Final results of a randomized controlled study. Hepatogastroenterology 2001;48:1776-1782.
16. Zhang GY, Chen XC, Pan K, Xia LG, Zuo M, Zheng T. Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer. Chin J Gastrointest Surg 2007;10:362-364.
17. Zhan HJ, Liang H, Wang BG, Deng JY, Hao XS. Efficacy of intraoperative hyperthermic peritoneal perfusion on 60 patients with advanced gastric carcinoma. Chin J Clin Oncol 2010;37:229-231.
18. Zhang WS, Su DM, Wang K, Yi PT, Zhou HT, Guo JJ. Clinical study of intraoperative hyperthermic intraperitoneal chemotherapy for preventing the peritoneal recurrence of advanced gastric carcinoma. Shanxi Med J 1998;27:67-69.
19. Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007;99:601-607.
20. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730.
21. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
22. Eppink B, Krawczyk PM, Stap J, Kanaar R. Hyperthermiainduced DNA repair deficiency suggests novel therapeutic anti-cancer strategies. Int J Hyperthermia 2012;28:509-517.
23. Routt SM, Zhu J, Zaleski JM, Dynlacht JR. Potentiation of metalloenediyne cytotoxicity by hyperthermia. Int J Hyperthermia 2011;27:435-444.
24. Frey B, Weiss EM, Rubner Y, Wunderlich R, Ott OJ, Sauer R, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 2012;28:528-542.
25. Knippertz I, Stein MF, Dorrie J, Schaft N, Muller I, Deinzer A, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia 2011;27:591-603.
26. Mace TA, Zhong L, Kokolus KM, Repasky EA. Effector CD8+ T cell IFN-gamma production and cytotoxicity are enhanced by mild hyperthermia. Int J Hyperthermia 2012;28:9-18.
27. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14:2702-2713.
28. Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Metaanalysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004;10:2727-2730.
29. Tan CQ, Wang XJ, Xu YK, Jiang BN, Zeng FH. Clinical studies on prevention of post-operational intraperitoneal neoplasm seeding of advanced gastric cancer by surgery combined with intraperitoneal perfusion of hyperthermic mitomycin C. J Pract Oncol 2000;15:165-168.
30. Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Gastric cancer treatment: A systematic review. Oncol Rep 2004;11:911-916.
31. Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis. World J Gastroenterol 2010;16:5621-5628.
32. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials. Eur J Cancer 1999;35:1059-1064.
33. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000;11:837-843.
34. Liu TS, Wang Y, Chen SY, Sun YH. An updated metaanalysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol 2008;34:1208-1216.
35. Chen XZ, Yang K, Liu J, Chen XL, Hu JK. Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World J Gastroenterol 2011;17: 4542-4544.
36. Ikeguchi M, Kondou A, Oka A, Tsujitani S, Maeta M, Kaibara N. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 1995;161:581-586.
37. Lu Q, Huang XJ, Luo YF, Yang DS, Chen C. Intraoperative intraperitoneal hypotonic thermoperfusion chemotherapy for advanced gastric cancer. J Clin Experim Med 2007;6:29-30.
38. Luo YF, Lu Q, Huang XJ, Yang DS, Chen C. Countermeasures of nursing in advanced gastric cancer by intraoperative intraperitoneal hypotonic thermoperfusion chemotherapy. Int Med Health Guid News (China) 2008;14:125-127.
39. Zhang B, Jiang ZH, Fang XD, Hong Y. Influence of hypotonic intraoperative intraperitoneal chemohyperthermia (HIPCH) on the long term survival of patients with gastric cancer. Chin J Gastrointest Surg 2004;7:289-291.
40. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487-497.
41. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001;17:1-18.
42. Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: Systematic review of current results. J Cancer Res Clin Oncol 2009;135:1637-1645.
43. De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009;3:CD006269.
44. Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. Cochrane Database Syst Rev 2010;1:CD006377.
45. Sakurai H, Hayakawa K, Mitsuhashi N, Tamaki Y, Nakayama Y, Kurosaki H, et al. Effect of hyperthermia combined with external radiation therapy in primary nonsmall cell lung cancer with direct bony invasion. Int J Hyperthermia 2002;18:472-483.
46. Hua Y, Ma S, Fu Z, Hu Q, Wang L, Piao Y. Intracavity hyperthermia in nasopharyngeal cancer: A phase III clinical study. Int J Hyperthermia 2011;27:180-186.
47. Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ. The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study. Int J Hyperthermia 2011;27:27-32.
48. Ishikawa T, Kokura S, Sakamoto N, Ando T, Imamoto E, Hattori T, et al. Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. Int J Hyperthermia 2012;28:597-604.
49. Bergs JW, Franken NA, Haveman J, Geijsen ED, Crezee J, van Bree C. Hyperthermia, cisplatin and radiation trimodality treatment: A promising cancer treatment? A review from preclinical studies to clinical application. Int J Hyperthermia 2007;23:329-341.
50. Mi DH, Li Z, Yang KH, Tian JH, Wang DY. HRCT for nonsmall cell lung cancer: A meta-analysis. Chin J Evidence-Based Med 2011;11:1262-1267.
51. Sugimachi K, Kitamura K, Baba K, Ikebe M, Morita M, Matsuda H, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus -A prospective randomized trial. Int J Hyperthermia 1992;8:289-295.
52. Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial. Int J Hyperthermia 1994;10: 485-493.
53. Hulshof MC, Van Haaren PM, Van Lanschot JJ, Richel DJ, Fockens P, Oldenborg S, et al. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer. Int J Hyperthermia 2009;25: 79-85.
54. Kang MK, Kim MS, Kim JH. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Hyperthermia 2011;27: 482-490.
55. Ghahremani FH, Sazgarnia A, Bahreyni-Toosi MH, Rajabi O, Aledavood A. Efficacy of microwave hyperthermia and chemotherapy in the presence of gold nanoparticles: An in vitro study on osteosarcoma. Int J Hyperthermia 2011;27: 625-636.
56. Golneshan AA, Lahonian M. The effect of magnetic nanoparticle dispersion on temperature distribution in a spherical tissue in magnetic fluid hyperthermia using the lattice Boltzmann method. Int J Hyperthermia 2011;27: 266-274.
57. Ishihara Y, Ohwada H. Non-invasive temperature measurement by using phase changes in electromagnetic waves in a cavity resonator. Int J Hyperthermia 2011;27:726-736.
58. Raoof M, Zhu C, Kaluarachchi WD, Curley SA. Luciferasebased protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: Developing an intracellular thermometer. Int J Hyperthermia 2012;28: 202-209.
59. van Dongen KW, Verweij MD. A feasibility study for noninvasive thermometry using non-linear ultrasound. Int J Hyperthermia 2011;27:612-624.